XELODA and Lapatinib Advanced or Metastatic Breast Cancer Blood products NCT00078572

Blood products
Description

Blood products

Alias
UMLS CUI-1
C0456388
Were any blood products given to the subject at any time between 2 weeks prior to the first dose of investigational product and 30 days post discontinuation of investigational product?
Description

blood products

Data type

text

Alias
UMLS CUI [1]
C0456388
Date started
Description

If YES, record below:

Data type

date

Alias
UMLS CUI [1,1]
C0808070
UMLS CUI [1,2]
C0456388
Blood product
Description

Blood product

Data type

integer

Alias
UMLS CUI [1,1]
C0456388
UMLS CUI [1,2]
C0332307
Blood product, if other please specify
Description

Blood product

Data type

text

Alias
UMLS CUI [1,1]
C0456388
UMLS CUI [1,2]
C0332307

Similar models

XELODA and Lapatinib Advanced or Metastatic Breast Cancer Blood products NCT00078572

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Blood products
C0456388 (UMLS CUI-1)
Item
Were any blood products given to the subject at any time between 2 weeks prior to the first dose of investigational product and 30 days post discontinuation of investigational product?
text
C0456388 (UMLS CUI [1])
Code List
Were any blood products given to the subject at any time between 2 weeks prior to the first dose of investigational product and 30 days post discontinuation of investigational product?
CL Item
Yes (Y)
CL Item
No (N)
Date started
Item
Date started
date
C0808070 (UMLS CUI [1,1])
C0456388 (UMLS CUI [1,2])
Item
Blood product
integer
C0456388 (UMLS CUI [1,1])
C0332307 (UMLS CUI [1,2])
Code List
Blood product
CL Item
Whole blood (1)
CL Item
Red cells (2)
CL Item
Platelets - concentrate  (3)
CL Item
Plasma - FFP (4)
CL Item
Cryoprecipitate (5)
CL Item
Factor VIII (6)
CL Item
Other, specify text in the box (99)
Blood product
Item
Blood product, if other please specify
text
C0456388 (UMLS CUI [1,1])
C0332307 (UMLS CUI [1,2])